Medical College of Wisconsin Researcher Describes Research in Chronic Myeloid Leukemia [Treatment with Asciminib As a Second Line after One Prior Tyrosine Kinase Inhibitor (TKI) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) - ...]

Source :: Obesity, Fitness & Wellness Week. December 28, 2024, 1617
Publication Year :: 2024
Abstract: 2024 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in chronic myeloid leukemia. According to news reporting [...]

Subjects :: Tyrosine -- Research
Oncology, Experimental
Nilotinib -- Research
Phenols -- Research
Chronic myeloid leukemia -- Drug therapy -- Research
Cancer -- Care and treatment -- Research
Medical colleges -- Research
Physical fitness -- Research
Health

Tools